Financial Information | ImmuneMed

Financial Information

Separate Financial Statements


Balance Sheet (Summary)

(Unit : million KRW)

Balance Sheet (Summary) 정보
  FY 2020 FY 2021 FY 2022
Assets      
Current Assets 1,905 10,815 13,503
Non-current assets 7,344 11,905 599
Total assets 9,249 22,720 14,102
Liabilities      
Current liabilities 54,522 32,350 31,823
Non-current liabilities 2,715 4,928 5,796
Total Liabilities 57,237 37,278 37,619
Equity      
Share capital 1,242 6,600 6,600
Share premium 10,472 64,108 64,108
Accumulated other comprehensive income - - -
Other components of equity 1,209 1,844 2,582
Retained earnings (60,911) (87,111) (96,807)
Total Equity (47,988) (14,559) (23,517)


Statement of Comprehensive Income (Summary)

(Unit : million KRW)

Statement of Comprehensive Income (Summary) 정보
  FY 2020 FY 2021 FY 2022
Sales  320 750 656
Cost of sales (505) (838) (580)
Gross profit (185) (88) 76
Selling General Administrative Expenses (12,480) (14,207) (15,766)
Operating Income (12,665) (14,295) (15,690)
Income and loss before income taxes (17,651) (26,200) (9,696)
Net income (17,651) (26,200) (9,696)
Other comprehensive income - - -
Total comprehensive income (17,651) (26,200) (9,696)

Consolidated Financial Statements


Balance Sheet (Summary)

(Unit : million KRW)

Balance Sheet (Summary) 정보
  FY 2020 FY 2021 FY 2022
Assets      
Current Assets 1,963 10,897 13,548
Non-current assets 7,343 11,905 599
Total assets 9,306 22,802 14,147
Liabilities      
Current liabilities 54,598 32,352 32,205
Non-current liabilities 2,715 4,928 5,796
Total Liabilities 57,313 37,280 38,001
Equity      
Share capital 1,242 6,600 6,600
Share premium 10,472 64,108 64,108
Accumulated other comprehensive income (28) (52) (35)
Other components of equity 1,208 1,844 2,582
Retained earnings (60,901) (86,977) (97,109)
Total Equity (48,007) (14,477) (23,854)


Statement of Comprehensive Income (Summary)

(Unit : million KRW)

Statement of Comprehensive Income (Summary) 정보
  FY 2020 FY 2021 FY 2022
Sales  320 750 656
Cost of sales (505) (838) (580)
Gross profit (185) (88) 76
Selling General Administrative Expenses (12,908) (15,743) (15,967)
Operating Income (13,093) (15,831) (15,891)
Income and loss before income taxes (17,182) (26,076) (10,131)
Net income (17,182) (26,076) (10,131)
Other comprehensive income (27) (24) 16
Total comprehensive income (17,209) (26,100) (10,115)